tiprankstipranks
HAVN Life Sciences (HAVLF)
OTHER OTC:HAVLF
US Market

HAVN Life Sciences (HAVLF) Income Statement

Compare
31 Followers

HAVN Life Sciences Income Statement

Last quarter (Q2 2023), HAVN Life Sciences's total revenue was C$0.00, a decrease of -100.00% from the same quarter last year. In Q2, HAVN Life Sciences's net income was C$0.00. See HAVN Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 23Jun 22Jun 21Jun 20
Total Revenue
C$ 0.00C$ 276.47KC$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 89.69KC$ -4.60MC$ 0.00
Operating Expenses
C$ 0.00C$ 9.90MC$ 25.75MC$ 41.12K
Depreciation and Amortization
C$ 228.49KC$ 575.62KC$ 4.58MC$ 171.86K
EBITDA
C$ 0.00C$ -21.80MC$ -25.76MC$ -40.58K
Operating Income
C$ 0.00C$ -9.81MC$ -30.35MC$ -40.58K
Other Income/Expenses
C$ 0.00C$ -12.63MC$ -27.49KC$ -446.34K
Pretax Income
C$ 0.00C$ -22.44MC$ -30.38MC$ -40.58K
Net Income
C$ 0.00C$ -22.44MC$ -30.38MC$ -40.58K
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ 0.00C$ -5.25C$ -8.47C$ -0.39
Diluted EPS
C$ 0.00C$ -5.25C$ -8.47C$ -0.39
Weighted Average Shares Outstanding
0.00 4.28M 3.59M 104.05K
Weighted Average Shares Outstanding (Diluted)
0.00 4.28M 3.59M 104.05K
Currency in CAD

HAVN Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis